Summary
For Year 2026-27, Strides Pharma Science reports the following shareholding: Total Promoters at 27.91%, Mutual Fund at 8.56%, Insurance at 4.54%, Foreign Institutional Investors at 28.68%, Domestic Institutional Investors at 1.36%, and Retail at 28.95%. This breakdown provides a quick snapshot of ownership distribution for Strides Pharma Science in 2026-27.
Strides Pharma Science FAQs
As of 04-2026, the promoter shareholding in Strides Pharma Science stands at 27.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Strides Pharma Science is 28.68% and 1.36% respectively.
The retail shareholding of the Strides Pharma Science is 28.95%.
Changes in shareholding patterns of Strides Pharma Science can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Strides Pharma Science are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Strides Pharma Science Associated Pages
- Strides Pharma Science Share Price
- Strides Pharma Science Share Price chart
- Strides Pharma Science Fundamental Analysis
- Strides Pharma Science Technical Analysis
- Strides Pharma Science Peer Comparison
- Strides Pharma Science Share Price History
- Strides Pharma Science Dividend
- Strides Pharma Science Board of Directors
